The development of MNMs may draw inspiration from current nano-platform technologies, and by endowing them with autonomous mobility capabilities, the development of MNMs may be accelerated
doi: 10.1096/fj.04-2915fje
We identify ADRB2, BCL3, EGR1, FOS, and MAP3K8 not merely as isolated targets but as components of a disease-associated regulatory network that is upregulated in MASLD
It does not tell us how much of that weight is fat versus muscle
I wish there was something I could do. With GLP-1 and G-agonists having the look of the hottest drug class in medical history, it is notable that a woman scientist and co-discoverer was sidelined from recognition
Serious adverse events appeared in 9.8% of the combination group, including two deaths (one suicide, one cancer)